Drug Profile
Eltenac
Alternative Names: B 78820; BY 820Latest Information Update: 24 Jun 2002
Price :
$50
*
At a glance
- Originator ALTANA Pharma
- Class Aniline compounds; Nonsteroidal anti-inflammatories; Small molecules; Thiophenes
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Osteoarthritis
Most Recent Events
- 24 Jun 2002 Discontinued - Clinical-Phase-Unknown for Osteoarthritis in Finland (Topical)
- 24 Jun 2002 Discontinued - Clinical-Phase-Unknown for Osteoarthritis in Sweden (Topical)
- 24 Jun 2002 Discontinued - Phase-I for Inflammation in Germany (PO)